| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Transplantation | 45 | 2023 | 908 | 5.930 |
Why?
|
| Heart Failure | 32 | 2023 | 2516 | 2.440 |
Why?
|
| Cardiomyopathies | 17 | 2023 | 610 | 2.210 |
Why?
|
| Heart-Assist Devices | 22 | 2022 | 1171 | 1.670 |
Why?
|
| Cardiomyopathy, Restrictive | 5 | 2020 | 20 | 1.430 |
Why?
|
| Cardiomyopathy, Hypertrophic | 7 | 2019 | 192 | 1.380 |
Why?
|
| Graft Rejection | 15 | 2023 | 834 | 1.230 |
Why?
|
| Death, Sudden, Cardiac | 7 | 2020 | 253 | 1.100 |
Why?
|
| Child | 82 | 2023 | 29154 | 1.040 |
Why?
|
| Cardiomyopathy, Dilated | 6 | 2022 | 244 | 0.990 |
Why?
|
| Myocarditis | 6 | 2019 | 190 | 0.950 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 4 | 2019 | 44 | 0.910 |
Why?
|
| Ventricular Function, Left | 9 | 2022 | 603 | 0.890 |
Why?
|
| Waiting Lists | 4 | 2020 | 263 | 0.860 |
Why?
|
| Donor Selection | 2 | 2020 | 110 | 0.850 |
Why?
|
| Heart Valve Diseases | 2 | 2021 | 193 | 0.830 |
Why?
|
| Child, Preschool | 59 | 2023 | 16273 | 0.810 |
Why?
|
| Pharmaceutical Preparations | 1 | 2022 | 152 | 0.730 |
Why?
|
| Heart Ventricles | 6 | 2022 | 846 | 0.730 |
Why?
|
| Organ Transplantation | 1 | 2022 | 191 | 0.690 |
Why?
|
| Adolescent | 56 | 2021 | 31252 | 0.660 |
Why?
|
| Echocardiography, Doppler | 4 | 2015 | 180 | 0.650 |
Why?
|
| Pericarditis | 1 | 2019 | 61 | 0.650 |
Why?
|
| Infant | 45 | 2021 | 13310 | 0.600 |
Why?
|
| Retrospective Studies | 54 | 2023 | 37905 | 0.570 |
Why?
|
| Immunosuppressive Agents | 3 | 2022 | 1375 | 0.550 |
Why?
|
| Ventricular Dysfunction, Left | 8 | 2017 | 435 | 0.540 |
Why?
|
| Ventricular Pressure | 1 | 2015 | 46 | 0.520 |
Why?
|
| Natriuretic Peptide, Brain | 7 | 2019 | 343 | 0.520 |
Why?
|
| Coronary Artery Disease | 4 | 2012 | 1011 | 0.520 |
Why?
|
| Heart Defects, Congenital | 8 | 2018 | 1697 | 0.510 |
Why?
|
| Muscle Cells | 1 | 2014 | 38 | 0.510 |
Why?
|
| Cardiac Catheterization | 7 | 2023 | 687 | 0.500 |
Why?
|
| Gestational Age | 1 | 2017 | 1069 | 0.480 |
Why?
|
| Cyclosporine | 1 | 2014 | 278 | 0.470 |
Why?
|
| Anemia, Iron-Deficiency | 3 | 2021 | 128 | 0.460 |
Why?
|
| Humans | 103 | 2023 | 261506 | 0.460 |
Why?
|
| Graft Survival | 8 | 2021 | 1062 | 0.450 |
Why?
|
| Tacrolimus | 1 | 2014 | 335 | 0.450 |
Why?
|
| Liver Transplantation | 1 | 2021 | 1112 | 0.430 |
Why?
|
| Prosthesis Implantation | 3 | 2020 | 263 | 0.420 |
Why?
|
| Male | 71 | 2023 | 123000 | 0.410 |
Why?
|
| Echocardiography | 7 | 2022 | 1182 | 0.410 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2011 | 44 | 0.400 |
Why?
|
| Body Mass Index | 3 | 2021 | 2203 | 0.390 |
Why?
|
| Infant, Newborn | 23 | 2023 | 8223 | 0.390 |
Why?
|
| Female | 74 | 2023 | 141928 | 0.380 |
Why?
|
| Ventricular Function, Right | 2 | 2022 | 111 | 0.370 |
Why?
|
| Heart Failure, Systolic | 2 | 2021 | 32 | 0.370 |
Why?
|
| Electrocardiography | 7 | 2019 | 1145 | 0.340 |
Why?
|
| Oxidative Stress | 1 | 2014 | 1129 | 0.320 |
Why?
|
| Cohort Studies | 15 | 2021 | 9244 | 0.320 |
Why?
|
| Tachycardia, Ventricular | 4 | 2016 | 239 | 0.320 |
Why?
|
| Parvoviridae Infections | 3 | 2013 | 38 | 0.320 |
Why?
|
| Stroke Volume | 7 | 2017 | 577 | 0.310 |
Why?
|
| Tissue Donors | 3 | 2021 | 769 | 0.290 |
Why?
|
| Postoperative Complications | 9 | 2022 | 5542 | 0.290 |
Why?
|
| Hospitals, Pediatric | 6 | 2018 | 773 | 0.280 |
Why?
|
| Treatment Outcome | 29 | 2022 | 32848 | 0.280 |
Why?
|
| Milrinone | 1 | 2006 | 33 | 0.280 |
Why?
|
| Infusions, Parenteral | 1 | 2006 | 191 | 0.270 |
Why?
|
| Registries | 5 | 2021 | 2170 | 0.270 |
Why?
|
| Cachexia | 1 | 2007 | 161 | 0.270 |
Why?
|
| Extracorporeal Membrane Oxygenation | 4 | 2019 | 581 | 0.270 |
Why?
|
| Leukopenia | 1 | 2005 | 151 | 0.260 |
Why?
|
| Hospitalization | 7 | 2022 | 2083 | 0.260 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2007 | 180 | 0.260 |
Why?
|
| Cardiotonic Agents | 1 | 2006 | 151 | 0.250 |
Why?
|
| Dopamine | 1 | 2006 | 312 | 0.240 |
Why?
|
| Coronary Stenosis | 1 | 2005 | 117 | 0.240 |
Why?
|
| Hospital Charges | 2 | 2015 | 75 | 0.240 |
Why?
|
| Body Weight | 1 | 2008 | 1293 | 0.230 |
Why?
|
| Diastole | 4 | 2020 | 187 | 0.230 |
Why?
|
| Leukocytes | 1 | 2005 | 422 | 0.230 |
Why?
|
| Parvovirus B19, Human | 3 | 2013 | 39 | 0.230 |
Why?
|
| Arrhythmias, Cardiac | 4 | 2022 | 473 | 0.230 |
Why?
|
| Exercise Test | 3 | 2016 | 312 | 0.230 |
Why?
|
| Mitral Valve | 2 | 2015 | 271 | 0.230 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 2 | 2022 | 32 | 0.230 |
Why?
|
| Multivariate Analysis | 7 | 2019 | 4298 | 0.220 |
Why?
|
| Tissue and Organ Procurement | 2 | 2020 | 233 | 0.220 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2016 | 112 | 0.210 |
Why?
|
| Young Adult | 11 | 2023 | 21445 | 0.210 |
Why?
|
| United States | 11 | 2022 | 15433 | 0.210 |
Why?
|
| Cardiac Output, Low | 3 | 2007 | 81 | 0.210 |
Why?
|
| Predictive Value of Tests | 10 | 2017 | 4892 | 0.210 |
Why?
|
| DNA, Viral | 3 | 2013 | 694 | 0.200 |
Why?
|
| Heart | 5 | 2022 | 1223 | 0.200 |
Why?
|
| Ambulatory Care | 1 | 2006 | 554 | 0.200 |
Why?
|
| Myocardium | 6 | 2023 | 1313 | 0.200 |
Why?
|
| Kaplan-Meier Estimate | 10 | 2021 | 6207 | 0.200 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2022 | 92 | 0.200 |
Why?
|
| Sarcomeres | 3 | 2022 | 42 | 0.200 |
Why?
|
| Connectin | 1 | 2020 | 30 | 0.190 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2022 | 226 | 0.190 |
Why?
|
| Hypertension, Pulmonary | 3 | 2016 | 462 | 0.190 |
Why?
|
| Wolff-Parkinson-White Syndrome | 2 | 2019 | 62 | 0.190 |
Why?
|
| Hemodynamics | 3 | 2022 | 935 | 0.190 |
Why?
|
| Age Factors | 6 | 2020 | 5377 | 0.180 |
Why?
|
| Kidney Transplantation | 2 | 2021 | 755 | 0.180 |
Why?
|
| Diuretics | 2 | 2022 | 170 | 0.180 |
Why?
|
| Noonan Syndrome | 1 | 2019 | 26 | 0.170 |
Why?
|
| Myocardial Contraction | 2 | 2020 | 291 | 0.170 |
Why?
|
| Biopsy | 4 | 2023 | 3443 | 0.170 |
Why?
|
| Survival Rate | 8 | 2021 | 12221 | 0.170 |
Why?
|
| Risk Assessment | 5 | 2020 | 6869 | 0.170 |
Why?
|
| Patient Admission | 2 | 2013 | 220 | 0.170 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2019 | 149 | 0.170 |
Why?
|
| Hospital Mortality | 4 | 2020 | 1274 | 0.160 |
Why?
|
| Troponin T | 1 | 2020 | 261 | 0.160 |
Why?
|
| Device Removal | 2 | 2018 | 337 | 0.160 |
Why?
|
| Defibrillators, Implantable | 2 | 2012 | 221 | 0.160 |
Why?
|
| Overweight | 1 | 2021 | 484 | 0.160 |
Why?
|
| Transforming Growth Factor beta | 1 | 2023 | 1130 | 0.160 |
Why?
|
| Tracheostomy | 1 | 2020 | 243 | 0.160 |
Why?
|
| Vascular Resistance | 2 | 2016 | 200 | 0.160 |
Why?
|
| Risk Factors | 14 | 2019 | 17523 | 0.150 |
Why?
|
| Aortic Valve | 1 | 2021 | 581 | 0.150 |
Why?
|
| Amino Acids | 1 | 2020 | 728 | 0.150 |
Why?
|
| Surgical Fixation Devices | 1 | 2017 | 3 | 0.150 |
Why?
|
| Adult | 14 | 2023 | 77950 | 0.150 |
Why?
|
| Pectus Carinatum | 1 | 2017 | 4 | 0.150 |
Why?
|
| Follow-Up Studies | 13 | 2019 | 14889 | 0.150 |
Why?
|
| Walking | 1 | 2019 | 277 | 0.150 |
Why?
|
| Titanium | 1 | 2017 | 61 | 0.150 |
Why?
|
| Natriuretic Agents | 2 | 2007 | 31 | 0.150 |
Why?
|
| Obesity | 2 | 2021 | 2884 | 0.150 |
Why?
|
| Wound Closure Techniques | 1 | 2017 | 28 | 0.150 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2017 | 51 | 0.140 |
Why?
|
| Loeys-Dietz Syndrome | 1 | 2017 | 37 | 0.140 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2020 | 5539 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2016 | 64 | 0.140 |
Why?
|
| Prognosis | 11 | 2019 | 21713 | 0.140 |
Why?
|
| Clostridium Infections | 1 | 2019 | 252 | 0.140 |
Why?
|
| Consensus | 1 | 2020 | 978 | 0.130 |
Why?
|
| Hypertrophy | 1 | 2016 | 162 | 0.130 |
Why?
|
| Thrombosis | 1 | 2022 | 781 | 0.130 |
Why?
|
| Acute Disease | 2 | 2019 | 2422 | 0.130 |
Why?
|
| Gadolinium DTPA | 1 | 2016 | 172 | 0.130 |
Why?
|
| Heart Septum | 1 | 2015 | 54 | 0.130 |
Why?
|
| Texas | 7 | 2018 | 6311 | 0.130 |
Why?
|
| Hyponatremia | 1 | 2016 | 82 | 0.130 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2016 | 136 | 0.130 |
Why?
|
| Time Factors | 9 | 2020 | 12926 | 0.130 |
Why?
|
| Ventricular Dysfunction | 1 | 2015 | 33 | 0.130 |
Why?
|
| Prosthesis Design | 4 | 2020 | 749 | 0.130 |
Why?
|
| Immunocompromised Host | 1 | 2019 | 698 | 0.130 |
Why?
|
| Anthracyclines | 1 | 2017 | 331 | 0.130 |
Why?
|
| Global Health | 1 | 2020 | 657 | 0.130 |
Why?
|
| Arterial Pressure | 1 | 2015 | 107 | 0.120 |
Why?
|
| Heart Arrest | 2 | 2017 | 358 | 0.120 |
Why?
|
| Prosthesis Failure | 1 | 2015 | 206 | 0.120 |
Why?
|
| Ebstein Anomaly | 1 | 2014 | 20 | 0.120 |
Why?
|
| Mortality | 1 | 2016 | 343 | 0.120 |
Why?
|
| Fontan Procedure | 1 | 2016 | 155 | 0.120 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2014 | 76 | 0.110 |
Why?
|
| Endocardium | 1 | 2013 | 50 | 0.110 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2014 | 180 | 0.110 |
Why?
|
| Kidney Failure, Chronic | 1 | 2021 | 960 | 0.110 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2017 | 726 | 0.110 |
Why?
|
| Ultrasonography | 2 | 2012 | 1863 | 0.110 |
Why?
|
| Comorbidity | 4 | 2019 | 2352 | 0.110 |
Why?
|
| Down Syndrome | 1 | 2016 | 226 | 0.110 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2016 | 218 | 0.110 |
Why?
|
| Coronary Angiography | 1 | 2016 | 598 | 0.110 |
Why?
|
| Anemia | 1 | 2018 | 689 | 0.110 |
Why?
|
| Pregnancy Outcome | 1 | 2016 | 643 | 0.110 |
Why?
|
| Aorta | 1 | 2017 | 692 | 0.110 |
Why?
|
| Recovery of Function | 4 | 2020 | 703 | 0.110 |
Why?
|
| Myocardial Ischemia | 1 | 2016 | 435 | 0.100 |
Why?
|
| Pseudomonas Infections | 1 | 2013 | 156 | 0.100 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2016 | 830 | 0.100 |
Why?
|
| Anticoagulants | 2 | 2022 | 787 | 0.100 |
Why?
|
| Pulmonary Artery | 1 | 2015 | 499 | 0.100 |
Why?
|
| Endomyocardial Fibrosis | 1 | 2010 | 9 | 0.100 |
Why?
|
| Reproducibility of Results | 3 | 2022 | 6009 | 0.100 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2010 | 23 | 0.100 |
Why?
|
| Incidence | 7 | 2017 | 5673 | 0.100 |
Why?
|
| Candidiasis | 1 | 2013 | 262 | 0.090 |
Why?
|
| DNA-Binding Proteins | 1 | 2023 | 4821 | 0.090 |
Why?
|
| Tachycardia | 2 | 2013 | 70 | 0.090 |
Why?
|
| Immunologic Factors | 1 | 2014 | 649 | 0.090 |
Why?
|
| Health Care Costs | 1 | 2015 | 674 | 0.090 |
Why?
|
| Death, Sudden | 1 | 2010 | 59 | 0.090 |
Why?
|
| Chronic Disease | 1 | 2016 | 1819 | 0.090 |
Why?
|
| Proportional Hazards Models | 6 | 2019 | 4988 | 0.090 |
Why?
|
| Genome, Viral | 1 | 2010 | 155 | 0.090 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2015 | 563 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 4744 | 0.090 |
Why?
|
| Renal Insufficiency | 2 | 2015 | 321 | 0.080 |
Why?
|
| Algorithms | 2 | 2011 | 3890 | 0.080 |
Why?
|
| Systole | 3 | 2022 | 196 | 0.080 |
Why?
|
| Databases, Factual | 4 | 2017 | 2218 | 0.080 |
Why?
|
| Intensive Care Units | 1 | 2013 | 717 | 0.080 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2013 | 489 | 0.080 |
Why?
|
| Histocompatibility Testing | 1 | 2010 | 447 | 0.080 |
Why?
|
| Pacemaker, Artificial | 2 | 2017 | 213 | 0.080 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2010 | 323 | 0.080 |
Why?
|
| Hypotension | 1 | 2009 | 210 | 0.080 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 2265 | 0.080 |
Why?
|
| HLA Antigens | 1 | 2010 | 546 | 0.080 |
Why?
|
| Virus Diseases | 1 | 2011 | 398 | 0.070 |
Why?
|
| Staphylococcal Infections | 1 | 2013 | 672 | 0.070 |
Why?
|
| Glomerular Filtration Rate | 2 | 2021 | 602 | 0.070 |
Why?
|
| Transplant Recipients | 2 | 2020 | 324 | 0.070 |
Why?
|
| Transplantation Immunology | 1 | 2007 | 97 | 0.070 |
Why?
|
| Antibodies | 1 | 2010 | 838 | 0.070 |
Why?
|
| Genotype | 2 | 2016 | 4109 | 0.070 |
Why?
|
| Heart Diseases | 2 | 2010 | 732 | 0.070 |
Why?
|
| Nutritional Status | 1 | 2008 | 337 | 0.070 |
Why?
|
| Length of Stay | 3 | 2019 | 1900 | 0.070 |
Why?
|
| Glycogen Storage Disease Type IIb | 1 | 2005 | 5 | 0.070 |
Why?
|
| Syndrome | 2 | 2008 | 1351 | 0.070 |
Why?
|
| Signal Transduction | 1 | 2023 | 11965 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 2315 | 0.060 |
Why?
|
| Codon, Nonsense | 1 | 2005 | 164 | 0.060 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2017 | 303 | 0.060 |
Why?
|
| Disease Progression | 3 | 2016 | 6682 | 0.060 |
Why?
|
| Tertiary Care Centers | 2 | 2019 | 403 | 0.060 |
Why?
|
| Arginine Vasopressin | 1 | 2004 | 60 | 0.060 |
Why?
|
| Cause of Death | 1 | 2007 | 752 | 0.060 |
Why?
|
| Gene Knock-In Techniques | 1 | 2023 | 171 | 0.060 |
Why?
|
| Resuscitation | 1 | 2005 | 223 | 0.060 |
Why?
|
| Probability | 2 | 2019 | 866 | 0.050 |
Why?
|
| Abdominal Pain | 1 | 2005 | 369 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 4938 | 0.050 |
Why?
|
| Kidney Diseases | 1 | 2008 | 691 | 0.050 |
Why?
|
| Chlorides | 1 | 2022 | 139 | 0.050 |
Why?
|
| Hirudins | 1 | 2022 | 65 | 0.050 |
Why?
|
| Prevalence | 3 | 2018 | 3260 | 0.050 |
Why?
|
| Antithrombins | 1 | 2022 | 74 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2023 | 7226 | 0.050 |
Why?
|
| Transferrin | 1 | 2021 | 78 | 0.050 |
Why?
|
| Actin Cytoskeleton | 1 | 2022 | 82 | 0.050 |
Why?
|
| Exercise | 1 | 2009 | 1183 | 0.050 |
Why?
|
| Thinness | 1 | 2021 | 82 | 0.050 |
Why?
|
| Hemolysis | 1 | 2021 | 127 | 0.050 |
Why?
|
| Electrocardiography, Ambulatory | 2 | 2016 | 66 | 0.050 |
Why?
|
| Severity of Illness Index | 4 | 2016 | 4320 | 0.050 |
Why?
|
| Critical Care | 1 | 2007 | 770 | 0.050 |
Why?
|
| Sodium | 1 | 2022 | 353 | 0.050 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2020 | 117 | 0.050 |
Why?
|
| Survival Analysis | 2 | 2009 | 9180 | 0.050 |
Why?
|
| Coronary Vessels | 1 | 2005 | 665 | 0.050 |
Why?
|
| Echocardiography, Doppler, Color | 2 | 2015 | 126 | 0.050 |
Why?
|
| Prospective Studies | 5 | 2018 | 12873 | 0.050 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2020 | 62 | 0.050 |
Why?
|
| Heparin | 1 | 2022 | 360 | 0.050 |
Why?
|
| Catheter Ablation | 1 | 2005 | 620 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2022 | 492 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2019 | 80 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2019 | 59 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 14289 | 0.040 |
Why?
|
| Phenotype | 1 | 2010 | 6295 | 0.040 |
Why?
|
| ROC Curve | 2 | 2016 | 1183 | 0.040 |
Why?
|
| Cytoskeleton | 1 | 2020 | 267 | 0.040 |
Why?
|
| Bilirubin | 1 | 2019 | 221 | 0.040 |
Why?
|
| Unnecessary Procedures | 1 | 2019 | 104 | 0.040 |
Why?
|
| Iron | 1 | 2021 | 376 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2006 | 1148 | 0.040 |
Why?
|
| Myocytes, Cardiac | 1 | 2023 | 764 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2022 | 549 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2019 | 6100 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2022 | 712 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2020 | 584 | 0.040 |
Why?
|
| Heart Atria | 1 | 2020 | 352 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2020 | 745 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2019 | 665 | 0.040 |
Why?
|
| Exons | 1 | 2020 | 1328 | 0.040 |
Why?
|
| Animals | 3 | 2023 | 59536 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2022 | 2927 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2022 | 1271 | 0.040 |
Why?
|
| Genes, ras | 1 | 2019 | 667 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 7702 | 0.030 |
Why?
|
| Respiration, Artificial | 1 | 2019 | 577 | 0.030 |
Why?
|
| Mutation | 2 | 2019 | 15179 | 0.030 |
Why?
|
| Heart Septal Defects | 1 | 2016 | 51 | 0.030 |
Why?
|
| Fetal Heart | 1 | 2016 | 105 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2017 | 338 | 0.030 |
Why?
|
| Cardiotoxicity | 1 | 2017 | 155 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2019 | 644 | 0.030 |
Why?
|
| Recurrence | 2 | 2019 | 4758 | 0.030 |
Why?
|
| Oxygen | 1 | 2019 | 754 | 0.030 |
Why?
|
| Stroke | 2 | 2015 | 1144 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2012 | 3203 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2023 | 5637 | 0.030 |
Why?
|
| ras Proteins | 1 | 2019 | 770 | 0.030 |
Why?
|
| Allografts | 1 | 2017 | 650 | 0.030 |
Why?
|
| Computed Tomography Angiography | 1 | 2017 | 234 | 0.030 |
Why?
|
| Vasodilator Agents | 1 | 2016 | 219 | 0.030 |
Why?
|
| Logistic Models | 1 | 2021 | 3441 | 0.030 |
Why?
|
| Renal Dialysis | 1 | 2021 | 945 | 0.030 |
Why?
|
| Pseudomonas | 1 | 2013 | 21 | 0.030 |
Why?
|
| Atrial Flutter | 1 | 2013 | 21 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2006 | 2195 | 0.030 |
Why?
|
| Staphylococcus | 1 | 2013 | 86 | 0.030 |
Why?
|
| Drug Resistance | 1 | 2014 | 587 | 0.030 |
Why?
|
| Airway Obstruction | 1 | 2016 | 261 | 0.030 |
Why?
|
| Arkansas | 1 | 2012 | 58 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 1085 | 0.030 |
Why?
|
| Respiratory Insufficiency | 1 | 2015 | 330 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2016 | 1471 | 0.030 |
Why?
|
| Biomarkers | 3 | 2009 | 5047 | 0.030 |
Why?
|
| Mice | 2 | 2023 | 34495 | 0.030 |
Why?
|
| Candida | 1 | 2013 | 164 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2015 | 945 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2016 | 2316 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 3719 | 0.020 |
Why?
|
| Morbidity | 1 | 2012 | 397 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2019 | 929 | 0.020 |
Why?
|
| Coxsackievirus Infections | 1 | 2010 | 17 | 0.020 |
Why?
|
| Enterovirus | 1 | 2010 | 63 | 0.020 |
Why?
|
| Adenoviridae Infections | 1 | 2010 | 125 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2013 | 1546 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2003 | 5270 | 0.020 |
Why?
|
| Apoptosis | 1 | 2023 | 7591 | 0.020 |
Why?
|
| Contrast Media | 1 | 2016 | 1472 | 0.020 |
Why?
|
| Herpesvirus 4, Human | 1 | 2013 | 966 | 0.020 |
Why?
|
| Isoantibodies | 1 | 2008 | 115 | 0.020 |
Why?
|
| Medical Records | 1 | 2009 | 415 | 0.020 |
Why?
|
| Immunoassay | 1 | 2008 | 216 | 0.020 |
Why?
|
| Assisted Circulation | 1 | 2007 | 37 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 2008 | 192 | 0.020 |
Why?
|
| Diuresis | 1 | 2007 | 63 | 0.020 |
Why?
|
| Endothelin-1 | 1 | 2007 | 60 | 0.020 |
Why?
|
| Renin | 1 | 2007 | 92 | 0.020 |
Why?
|
| Aldosterone | 1 | 2007 | 72 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2013 | 899 | 0.020 |
Why?
|
| Norepinephrine | 1 | 2007 | 272 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2008 | 571 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2007 | 418 | 0.020 |
Why?
|
| Sepsis | 1 | 2012 | 652 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2010 | 764 | 0.020 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2005 | 12 | 0.020 |
Why?
|
| Papillary Muscles | 1 | 2005 | 27 | 0.020 |
Why?
|
| Shock, Cardiogenic | 1 | 2007 | 228 | 0.020 |
Why?
|
| Drug Overdose | 1 | 2006 | 81 | 0.020 |
Why?
|
| Creatinine | 1 | 2007 | 531 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 980 | 0.020 |
Why?
|
| Adenoviridae | 1 | 2010 | 1459 | 0.020 |
Why?
|
| Muscular Diseases | 1 | 2005 | 161 | 0.020 |
Why?
|
| Palliative Care | 1 | 2016 | 2037 | 0.020 |
Why?
|
| Reference Values | 1 | 2006 | 1099 | 0.020 |
Why?
|
| Heart Rate | 1 | 2007 | 737 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 4549 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2008 | 1363 | 0.010 |
Why?
|
| Mitochondrial Myopathies | 1 | 2003 | 28 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2010 | 2450 | 0.010 |
Why?
|
| Remission, Spontaneous | 1 | 2003 | 119 | 0.010 |
Why?
|
| Acyltransferases | 1 | 2003 | 62 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2005 | 475 | 0.010 |
Why?
|
| Bradycardia | 1 | 2004 | 70 | 0.010 |
Why?
|
| Observer Variation | 1 | 2005 | 671 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2008 | 1385 | 0.010 |
Why?
|
| Pulmonary Circulation | 1 | 2004 | 131 | 0.010 |
Why?
|
| Medical Errors | 1 | 2006 | 219 | 0.010 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2004 | 88 | 0.010 |
Why?
|
| Exercise Tolerance | 1 | 2004 | 107 | 0.010 |
Why?
|
| Outpatients | 1 | 2006 | 462 | 0.010 |
Why?
|
| Pregnancy | 1 | 2016 | 7573 | 0.010 |
Why?
|
| Inflammation | 1 | 2013 | 2522 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2005 | 1062 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2004 | 409 | 0.010 |
Why?
|
| Ultrasonography, Doppler | 1 | 2004 | 231 | 0.010 |
Why?
|
| Chest Pain | 1 | 2004 | 155 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2006 | 1382 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2004 | 401 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2005 | 1163 | 0.010 |
Why?
|
| Mass Screening | 1 | 2008 | 1509 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 4971 | 0.010 |
Why?
|
| Patient Selection | 1 | 2006 | 2055 | 0.010 |
Why?
|
| Kidney | 1 | 2007 | 2146 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2005 | 1270 | 0.010 |
Why?
|
| Proteins | 1 | 2003 | 1963 | 0.010 |
Why?
|